TW202442220A - 一種含vvn001的眼科組合物 - Google Patents

一種含vvn001的眼科組合物 Download PDF

Info

Publication number
TW202442220A
TW202442220A TW112140586A TW112140586A TW202442220A TW 202442220 A TW202442220 A TW 202442220A TW 112140586 A TW112140586 A TW 112140586A TW 112140586 A TW112140586 A TW 112140586A TW 202442220 A TW202442220 A TW 202442220A
Authority
TW
Taiwan
Prior art keywords
acid
sodium
ophthalmic composition
ophthalmic
osmotic pressure
Prior art date
Application number
TW112140586A
Other languages
English (en)
Chinese (zh)
Inventor
爾寧 夏
韓巧
旺 沈
陽清沁 陸
高紅妍
Original Assignee
大陸商維眸生物科技（浙江）有限公司 中國浙江省溫州市甌海區基因藥谷北區 B 幢 4020室
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大陸商維眸生物科技（浙江）有限公司 中國浙江省溫州市甌海區基因藥谷北區 B 幢 4020室 filed Critical 大陸商維眸生物科技（浙江）有限公司 中國浙江省溫州市甌海區基因藥谷北區 B 幢 4020室
Publication of TW202442220A publication Critical patent/TW202442220A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW112140586A 2023-04-27 2023-10-24 一種含vvn001的眼科組合物 TW202442220A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202310476403.2A CN118892446A (zh) 2023-04-27 2023-04-27 一种含vvn001的眼科组合物
CN2023104764032 2023-04-27

Publications (1)

Publication Number Publication Date
TW202442220A true TW202442220A (zh) 2024-11-01

Family

ID=93255459

Family Applications (1)

Application Number Title Priority Date Filing Date
TW112140586A TW202442220A (zh) 2023-04-27 2023-10-24 一種含vvn001的眼科組合物

Country Status (9)

Country Link
EP (1) EP4702974A1 (https=)
JP (1) JP2025516407A (https=)
KR (1) KR20240159657A (https=)
CN (1) CN118892446A (https=)
AU (1) AU2023361985B2 (https=)
CA (1) CA3238321A1 (https=)
IL (1) IL312531A (https=)
TW (1) TW202442220A (https=)
WO (1) WO2024221527A1 (https=)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0589020A4 (en) * 1992-03-18 1994-07-06 Coopervision Pharma Verapamil hcl formulation and other ophthalmic solutions with buffer system for ocular administration
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
HUE059052T2 (hu) * 2014-11-07 2022-10-28 Santen Pharmaceutical Co Ltd Vizes szemészeti készítmény
WO2019001171A1 (zh) * 2017-06-27 2019-01-03 维眸生物科技上海有限公司 一种含磷化合物及其制备和应用
CN109134533B (zh) * 2017-06-27 2020-08-11 维眸生物科技（上海）有限公司 一种含磷化合物及其制备和应用
CN114533652B (zh) * 2018-09-25 2024-12-13 沈阳兴齐眼药股份有限公司 药物组合物、其制备方法和用途
US20230172946A1 (en) * 2019-08-18 2023-06-08 Iview Therapeutics, Inc. In-situ Gel Forming Ophthalmic Formulations Containing Difluprednate
IT202000027155A1 (it) * 2020-11-12 2022-05-12 Sifi Spa Formulazione a base di poliesametilene biguanide per il trattamento della cheratite da acanthamoeba
PL4312986T3 (pl) * 2021-04-01 2025-02-17 Active Biotech Ab Preparat lakwinimodu do stosowania do oczu

Also Published As

Publication number Publication date
EP4702974A1 (en) 2026-03-04
JP2025516407A (ja) 2025-05-30
CN118892446A (zh) 2024-11-05
AU2023361985A1 (en) 2024-11-14
KR20240159657A (ko) 2024-11-05
CA3238321A1 (en) 2025-07-08
AU2023361985B2 (en) 2025-08-14
IL312531A (en) 2024-11-01
WO2024221527A1 (zh) 2024-10-31

Similar Documents

Publication Publication Date Title
US11052094B2 (en) D2O stabilized pharmaceutical formulations
US20240139166A1 (en) Ophthalmic compositions for presbyopia
US11701343B2 (en) Compositions and methods for treating ocular disorders
US20230041788A1 (en) Ophthalmic compositions comprising d2o
Gibson Ophthalmic dosage forms
JP2015197479A (ja) 眼科用組成液及びその使用方法
JP6582029B2 (ja) 眼科用組成液及びその使用方法
KR20110104367A (ko) 무보존제 안과용 조성물
TW202442220A (zh) 一種含vvn001的眼科組合物
GR1009419B (el) Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει εναν συνδυασμο βρινζολαμιδης και βριμονιδινης και μεθοδος για την παρασκευη αυτου
HK40113077A (zh) 一种含vvn001的眼科组合物
WO1990013284A1 (en) Pharmaceutical composition containing sodium cromoglycate
JP2025516407A5 (https=)
EP4230193A1 (en) Ophthalmic pharmaceutical composition
TW202442233A (zh) 一種用於治療非感染性炎症疾病的眼科組合物
HK40113256A (zh) 一种用於治疗非感染性炎症疾病的眼科组合物
US20260053780A1 (en) Compositions, methods, and systems for treating presbyopia
WO2024034592A1 (ja) Ｕｄｃａまたはその塩を含有する水性医薬組成物
KR20250064683A (ko) 안구 충혈 완화를 위한 아프라클로니딘을 포함하는 약제학적 조성물
AU2023316921A1 (en) Ophthalmic composition for treating non-infectious inflammatory diseases
HK40082459A (en) Ophthalmic compositions comprising d2o